Physician profile
Frank Eberheart
NPI 1134172521
$250.15
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.22 · 2022: $44.73 · 2023: $56.69 · 2024: $86.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $86.51 | 2024 | Evos |
| Abbvie INC. | $33.85 | 2022-2023 | |
| Orthogenrx INC. | $20.98 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.20 | 2023 | |
| Depuy Synthes Sales INC. | $18.80 | 2023 | Orthovisc, Monovisc |
| Novo Nordisk INC | $18.00 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.76 | 2022 | |
| Abbott Laboratories | $12.81 | 2022 | |
| Endo Pharmaceuticals INC. | $11.80 | 2021 | |
| Baudax Bio INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Eberheart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.